1. Renhe (Group) Development Co., Ltd.
Tigerson Yang,
3. cathay pacific fund-Bank of Communications-cathay pacific fund Yuan Bo No.20 Joint Venture.
4. Shanghai Pudong Development Bank Co., Ltd.-E Fund innovates in the future,
5. China Industrial and Commercial Bank Co., Ltd.-Yifangda Kexiang mixed certificate,
6. Bank of China Limited by Share Ltd-E Fund's certificate of balanced growth,
7. Renhe Pharmaceutical Co., Ltd. repurchased special securities accounts,
8. The basic old-age insurance fund 1205 combination,
9. Bank of China E Fund's steady growth securities investment fund,
10. Industrial and Commercial Bank of China Co., Ltd.-Flexible allocation of E Fund in new economy
I. renhe group
Renhe (Group) Development Co., Ltd. was established on 200 1. Is a modern pharmaceutical enterprise group dedicated to the research and development and promotion of traditional and high-tech pharmaceutical products. There are 1 listed companies, 8 backbone pharmaceutical production enterprises and 3 commercial logistics enterprises, with more than 5,000 employees.
Renhe group 1998 started its business, and 200 1 was established. With the cordial care of the party and governments at all levels and the enthusiastic help of all walks of life, through the hard work of all employees, it has now developed into a modern pharmaceutical enterprise group integrating research and development, production and sales of drugs and health care products. Since its establishment, it has achieved excellent results in sales revenue, tax contribution and other major economic indicators, doubling growth for six consecutive years and increasing by 66 times in 10.
Two. Renhe group's business scope
Chinese herbal medicine planting, seedling cultivation, carton production and sales, computer software development, packaging design, advertising planning and production, building materials, household appliances and hardware, department stores, chemicals (except dangerous chemicals), electromechanical (except automobiles), electronic products, cultural and sports office supplies, communication equipment (except radio transmitting equipment), automobile parts, metal materials wholesale and retail, industrial investment, capital operation and project consultation. Office building and workshop leasing. (Projects subject to approval according to law can only be operated after approval by relevant departments)
Renhe industrial enterprise has a modern production base with a total area of more than 600,000 square meters, and registered more than 400 varieties of Chinese and western medicines and health care products. Twenty-nine pharmaceutical dosage forms and eight health food dosage forms, including capsules, soft capsules, dropping pills, eye drops, granules, tablets, lotions and rubber ointments, have obtained national GMP certification, forming two major product production sectors.